FDA Investigator Vitaliy N Guyvan
Vitaliy N Guyvan has conducted inspections on 125 sites in 3 countries as of 01 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
125
Last Inspection Date:
01 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Fiji,
Israel
FDA Investigators that have inspected at least one site in common with Vitaliy N Guyvan:
Abby M Miller,
Abigail A Andersen,
Adam C Hipko,
Alan D Grupe,
Alcee M Tavarez,
Alicia Aborg Borm,
Alicia M Weitzel,
Alisa Boswell,
Amber M Howell,
Amy R Glynn,
Anh M Lac,
Ashleigh P Barkans,
Avery J Dennis,
Axel M Ambert,
Barbara J Rincon,
Belinda E Clifton,
Brenda K Alford,
Brian E Thompson,
Bruce R Burrell,
Camerson E Moore,
Camille Bennett Hoffman,
Catherine J Laufmann,
Ce'nedra M Martin,
Celia L Hutchinstein,
Charles D Brown,
Christopher L Jacobs,
Christopher S Genther,
Clint R Van Blaricom,
Connie P Rezendes,
Crystal A Harlan,
Dana M Lewis,
David A Quale,
David J Gomes,
David L Hunsaker,
Dawn E Barkans,
Debra D Devlieger,
Deidre R Edwards,
Denise Connelly,
Deniza Karacic,
Dennis R Hudson,
Devon M Shoop,
Dianne B Latona,
Dirk L Lincoln,
Don A Brunssen,
Donald B Mckechnie,
Elizabeth A Sheller,
Elizabeth S Howell,
Eric C Andes,
Eric C Milstead,
Eric L Scott,
Frans E Mercado,
Gerard Pde Leon,
Gina C Collins,
Gloria J Baca, MS,
Gordon T Wales,
Graham N Giesen,
Grant L Davis,
Hanna L Potter,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hyeongho Ha,
Ian J Thomson,
Indigo A Doll,
Jacob N Hamilton,
Jacob W Reynolds,
James C Cartwright,
James E Trabert,
James S Cartwright,
Jason T Lovelady,
Jason W Cornell,
Jean Brewer,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeff A Gard,
Jeffrey C Moncalieri,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jeffrey R Wooley,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jessie J Deloach,
Jinkee Mvila Binayug,
Jodi M Gatica,
John T Sproul,
Jonathan A Womack,
Jonathan T Little,
Jose Acruz Gonzalez,
Jose O Caraballo Rivera,
Joseph M Hudak,
Judy C Nepsa,
Julia E Chervoni,
Julia Ventura,
Justin A Boyd,
Kaitlyn R Kornberg,
Katharine Chan,
Katherine L Arnold,
Kathleen Chmura Shaffer,
Katlin N Stubbs,
Kayla R Deatherage,
Keegan B Mixon,
Kelsey A Hustedt,
Kelsey A Volkman,
Kenitra D Hewitt,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Khunnathee Stoner,
Kimberly Jproctor Jones,
Kristina M Phelps,
Lauren E Swantko,
Lauren L May,
Lenita R Silvera,
Leon R Marquart,
Lesley A Swanson,
Leya A Grosch,
Lisa A Bowden,
Lisa A Carpenter,
Lisa R Whitt,
Liza L Quiles,
Loan T Tran,
Mai Hang,
Marcus A Goshen,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark S Crippen,
Marsha L Mccauley,
Matthew R Barr,
Matthew S Mccollough,
Michael H Antee,
Michael S Hudson,
Michael S Valenzuela,
Michelle A Krayer,
Mikel T Wright,
Monique Rac Lester,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Ngoc Lan T Nguyen,
Noreen Muñiz,
Patty P Kaewussdangkul,
Paul E Frazier,
Paul F Rader,
Paul M Kawamoto,
Pauline N Logan,
Peter Kessler, PhD,
Peter T Regan,
Peter W Gothro,
Phillip J Sample,
Rachelle M Deskins,
Rebecca A Sletner,
Richard A Martin,
Richard G Runyon,
Robert J Vezzetti,
Rocco C Black,
Roger F Zabinski,
Ronald E Gill,
Ronald L Lahti,
Roy R Rinc,
S Lori Brown, PhD MPH,
Saijal P Naik,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Scott W Fox,
Shahriar Rahmani,
Shannon J Hall,
Shelagh D Schopen,
Sonia R Peterson,
Staci G Mcallister,
Stephanie A Jameson,
Stephen R Souza,
Sunitha K Rajaram, PhD,
Sunny R Muir,
Tamera H Hunt,
Tara A Marshall,
Terren L Cheesbro,
Theresa L Stewart,
Thomas C Mclean, CFS,
Timothy D Evans,
Timothy S Williamson,
Tracy K Li,
Vanessa Y Gelsey, PhD,
Willis L Hicks,
Zachary P Wachlarowicz,
Zhongren Wu
Vitaliy N Guyvan's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2018 | FDA 483 | Valley Processing, Inc. - Form 483, 2018-08-17 |
| January, 2024 | FDA 483 | Talisman LLC dba American Metabolix - Form 483, 2024-01-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more